Advent Pharma (DHA:ADVENT) Research & Development: BDT Mil (TTM As of . 20)


DHA:ADVENT Advent Pharma Ltd DHA:ADVENT
29 GF Score
Price BDT15.70
View Full Analysis

What is Advent Pharma Research & Development?

Advent Pharma DHA:ADVENT 29 Research & Development is BDT Mil as of . 20. GuruFocus rates DHA:ADVENT with a GF Score™ of 29/100.

Research & Development is the aggregate amount of research and development expenses during the year. Advent Pharma's Research & Development for the six months ended in . 20 was BDT0.00 Mil. Advent Pharma does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Advent Pharma  (DHA:ADVENT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Advent Pharma Research & Development Related Terms

Advent Pharma Research & Development Historical Data

* Premium members only.

The historical data trend for Advent Pharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advent Pharma Research & Development Chart

Advent Pharma Annual Data
Trend
Research & Development

Advent Pharma Semi-Annual Data
Research & Development
DHA:ADVENT
29GF Score
Advent Pharma Ltd DHA:ADVENT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advent Pharma Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of BDT Mil mean?
Advent Pharma (DHA:ADVENT) has a Research & Development of BDT Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Advent Pharma and its competitors.
Is Advent Pharma's Research & Development too high?
Advent Pharma's current Research & Development is BDT Mil. Overall, Advent Pharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Advent Pharma's Research & Development compare to ?
Advent Pharma's Research & Development of BDT Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Advent Pharma and its competitors. Advent Pharma's current Research & Development is BDT Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advent Pharma stock overvalued right now?
Advent Pharma (DHA:ADVENT) has a current Research & Development of BDT Mil. The current Research & Development is BDT Mil. Advent Pharma's overall GF Score™ is 29/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Advent Pharma (DHA:ADVENT), the current Research & Development is BDT Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advent Pharma Business Description

Comparable Companies
Address Kakrail V.I.P. Road, Level no. 10, 80, Rupayan Karim Tower, Kakrail, Ramna, Dhaka, BGD, 1000
Advent Pharma Ltd is a Bangladesh-based company engaged in producing animal healthcare drugs and nutritional supplements for livestock.
29GF Score

Get the complete analysis for DHA:ADVENT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT15.70
Price